These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 38166771)

  • 21. Peroxisome proliferator activated receptor gamma gene variants influence susceptibility and insulin related traits in Indian women with polycystic ovary syndrome.
    Shaikh N; Mukherjee A; Shah N; Meherji P; Mukherjee S
    J Assist Reprod Genet; 2013 Jul; 30(7):913-21. PubMed ID: 23748472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS).
    Tan S; Scherag A; Janssen OE; Hahn S; Lahner H; Dietz T; Scherag S; Grallert H; Vogel CI; Kimmig R; Illig T; Mann K; Hebebrand J; Hinney A
    BMC Med Genet; 2010 Jan; 11():12. PubMed ID: 20092643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum levels of TSP-1, NF-κB and TGF-β1 in polycystic ovarian syndrome (PCOS) patients in northern China suggest PCOS is associated with chronic inflammation.
    Liu M; Gao J; Zhang Y; Li P; Wang H; Ren X; Li C
    Clin Endocrinol (Oxf); 2015 Dec; 83(6):913-22. PubMed ID: 26391700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Genetic aspects of polycystic ovary syndrome].
    Jakubowski L
    Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential gene expression in granulosa cells from polycystic ovary syndrome patients with and without insulin resistance: identification of susceptibility gene sets through network analysis.
    Kaur S; Archer KJ; Devi MG; Kriplani A; Strauss JF; Singh R
    J Clin Endocrinol Metab; 2012 Oct; 97(10):E2016-21. PubMed ID: 22904171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of MEP1A gene variants with insulin metabolism in central European women with polycystic ovary syndrome.
    Lam UD; Lerchbaum E; Schweighofer N; Trummer O; Eberhard K; Genser B; Pieber TR; Obermayer-Pietsch B
    Gene; 2014 Mar; 537(2):245-52. PubMed ID: 24388959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptional and Epigenetic Changes Influencing Skeletal Muscle Metabolism in Women With Polycystic Ovary Syndrome.
    Nilsson E; Benrick A; Kokosar M; Krook A; Lindgren E; Källman T; Martis MM; Højlund K; Ling C; Stener-Victorin E
    J Clin Endocrinol Metab; 2018 Dec; 103(12):4465-4477. PubMed ID: 30113663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Luteinizing hormone and LH receptor gene polymorphism with susceptibility of Polycystic ovary syndrome.
    Deswal R; Nanda S; Dang AS
    Syst Biol Reprod Med; 2019 Oct; 65(5):400-408. PubMed ID: 30958034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin D Supplementation Decreases TGF-β1 Bioavailability in PCOS: A Randomized Placebo-Controlled Trial.
    Irani M; Seifer DB; Grazi RV; Julka N; Bhatt D; Kalgi B; Irani S; Tal O; Lambert-Messerlian G; Tal R
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4307-14. PubMed ID: 26485217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promoter methylation of yes-associated protein (YAP1) gene in polycystic ovary syndrome.
    Jiang LL; Xie JK; Cui JQ; Wei D; Yin BL; Zhang YN; Chen YH; Han X; Wang Q; Zhang CL
    Medicine (Baltimore); 2017 Jan; 96(2):e5768. PubMed ID: 28079802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphisms of vascular cell adhesion molecule1 (VCAM1) in polycystic ovary syndrome determined by quantitative real-time polymerase chain reaction and melting curve analysis.
    Kanmaz-Özer M; Vural P; Doğru-Abbasoğlu S; Gedikbaşı A; Çil E; Karadağ B; Uysal M
    Eur J Obstet Gynecol Reprod Biol; 2012 Feb; 160(2):174-8. PubMed ID: 22137570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA methylation in the pathogenesis of polycystic ovary syndrome.
    Vázquez-Martínez ER; Gómez-Viais YI; García-Gómez E; Reyes-Mayoral C; Reyes-Muñoz E; Camacho-Arroyo I; Cerbón M
    Reproduction; 2019 Jul; 158(1):R27-R40. PubMed ID: 30959484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of
    Alkhuriji AF; Al Omar SY; Babay ZA; El-Khadragy MF; Mansour LA; Alharbi WG; Khalil MI
    Dis Markers; 2020; 2020():6076274. PubMed ID: 32454906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.
    Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Yetkin I; Ayvaz G; Cakir N; Arslan M
    Gynecol Endocrinol; 2005 Oct; 21(4):206-10. PubMed ID: 16316841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphisms and haplotypes of insulin-like factor 3 gene are associated with risk of polycystic ovary syndrome in Indian women.
    Shaikh N; Dadachanji R; Meherji P; Shah N; Mukherjee S
    Gene; 2016 Feb; 577(2):180-6. PubMed ID: 26625974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic polymorphisms of INS, INSR and IRS-1 genes are not associated with polycystic ovary syndrome in Croatian women.
    Skrgatić L; Baldani DP; Gersak K; Cerne JZ; Ferk P; Corić M
    Coll Antropol; 2013 Mar; 37(1):141-6. PubMed ID: 23697264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen receptor αlpha gene (ESR1) PvuII and XbaI polymorphisms are associated to metabolic and proinflammatory factors in polycystic ovary syndrome.
    Silva FS; Sóter MO; Sales MF; Candido AL; Reis FM; Silva IF; Sousa MO; Ferreira CN; Gomes KB
    Gene; 2015 Apr; 560(1):44-9. PubMed ID: 25617525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calpain 10 gene single-nucleotide 44 polymorphism may have an influence on clinical and metabolic features in patients with polycystic ovary syndrome.
    Yilmaz M; Yurtçu E; Demirci H; Ergün MA; Ersoy R; Karakoç A; Yetkin I; Cakir N; Ayvaz G; Arslan M
    J Endocrinol Invest; 2009 Jan; 32(1):13-7. PubMed ID: 19337008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic regulation of an adverse metabolic phenotype in polycystic ovary syndrome: the impact of the leukocyte methylation of PPARGC1A promoter.
    Zhao H; Zhao Y; Ren Y; Li M; Li T; Li R; Yu Y; Qiao J
    Fertil Steril; 2017 Feb; 107(2):467-474.e5. PubMed ID: 27889100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promoter methylation of CYP19A1 gene in Chinese polycystic ovary syndrome patients.
    Yu YY; Sun CX; Liu YK; Li Y; Wang L; Zhang W
    Gynecol Obstet Invest; 2013; 76(4):209-13. PubMed ID: 24157654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.